|
17 Feb 2017 |
Social |
RT @DrRachelTate: Tofa as an option for AS? No FDA indication but a potential off label option. E. Ruderman MD #rwcs2017 @RWCSmtg @RheumNow… |
|
|
15 Sep 2016 |
Social |
RT @RonanTKavanagh: patients with psoriatic spondyloarthritis more steroid responsive than patients with Ank Spond (60% vs 20% at week 2. #… |
|
|
07 Nov 2017 |
Social |
RT @Lupusdoc: Poster title of the day....! #2556 @RheumNow #ACR17 https://t.co/nDmsAQQS19 |
|
|
14 Jun 2018 |
Social |
RT @DrPetryna: #EULAR18 @RheumNow ABST thu0297 CVRF higher in PSO, PsA & periph SpA w/o PSO comparing to gen pop but similar amongst the Dx… |
|
|
16 Oct 2017 |
Social |
Population survey found psoriasis/PsA in 1.4-3.3%; Nearly 1/2 not seeing MD or stopped biologic for safety/no effect https://t.co/JGHWuIUacK |
|
|
28 Mar 2017 |
Social |
RT @CBSHealth: FDA approves powerful new drug for eczema -- but it comes with a hefty price tag https://t.co/EOjOgCdoci https://t.co/V49wgh… |
|
|
17 Apr 2019 |
Social |
Comparing fibromyalgia, PsA, Psoriasis Pts - FM has more entheseal tenderness (92%) than PSA (66%) and PSO (59%). However with ultrasound, entheseal involvement were more frequent in PsA & psoriasis (~90%) vs FM (75%). What? US enthesitis in FM? https://t.co/wNBQEB3j0O |
|
|
23 Oct 2016 |
Social |
Dr. Sergio Schwartzman comments on new Ocular Screening Guidlines for Hydroxychloroquine at RheumNow https://t.co/Qm1iDM77Jo |
|
|
08 Jun 2016 |
Social |
Secukinumab data presented at EULAR; Novartis plans H2H trial of Cosentyx & Humira; details to follow https://t.co/zjA8Rgw0cX |
|
|
08 Nov 2017 |
Social |
RT @_connectedcare: Lots of different causes for Red Eye in autoimmune arthritis. Here’s a list #ACR17 @RheumNow https://t.co/pMi2tLMDpk |
|
|
13 Jan 2019 |
Social |
QD Video on RheumNow - an HLA-B27+ patient with Iritis, Enthesitis, Diarrhea. https://t.co/LusZttdAyw |
|
|
04 Nov 2017 |
Social |
RT @DrPetryna: GI mucosal associated invariant T (MAIT) cells detected in joints of patients w/AS. Expanding views of SpA #ACR17 Sunday pre… |
|
|
17 Jun 2019 |
Social |
RT @tuna0sashimi: FUTURE 5 secukinumab in PsA placebo arm only 12w. Week 52 pt can increase doses from 150mg to 300mg. 2y data presented. S… |
|
|
04 Jan 2017 |
Social |
NICE recommends apremilast for use in psoriatic arthritis w/in UK NHS. Risk of suidical ideation is 0.2% (3/1441) https://t.co/ZFDSo3B81u |
|
|
11 Nov 2015 |
Social |
Dr Atul Deodhar on video at RheumNow, discussing new therapies for ankylosing splondylitis. Live from #ACR15 https://t.co/wJFcAurQYE |
|
|
05 Nov 2017 |
Social |
RT @doctorakerkar: Therapies to look forward to in #AnkylosingSpondylitis
#ACR17 https://t.co/h9uZQ08wbD |
|
|
18 Jul 2017 |
Social |
320 pt Rheum-Derm clinic in Vancouver - lupus is most common rheum dx; dermatitis & psoriasis most common Derm Dx https://t.co/soA3UXsfXF |
|
|
29 Dec 2017 |
Social |
Causes of Dactylitis = PsA, AS, SpA, reactive arthritis, MCTD, PSS, TB, syphilis, JIA, Sarcoid https://t.co/nhotKuYF2n |
|
|
14 Oct 2018 |
Social |
RheumNow Wk in Review is up! Info on SSc-SSLE overlap, capillaroscopy fingers, Women with SpA, acute gout management and lupus patients in pain in the ED. Watch here https://t.co/wB10SaVXF7 Or checkout the podcasts at iTunes or here https://t.co/5GdSlCyWmW |
|
|
02 Jul 2015 |
Social |
Ixekizumab (anti-IL17) is superior to Enbrel in 1224 pts w/ plaque psoriasis (UNCOVER-2) w/ rapid decr in itch scores http://t.co/ozZbHEq6Wu |
|
